1,145 filings
Page 5 of 58
8-K
PDLI
PDL Biopharma Inc
20 Aug 20
Departure of Directors or Certain Officers
5:06pm
8-K
PDLI
PDL Biopharma Inc
12 Aug 20
PDL BioPharma Enters Into Settlement Agreement with Wellstat
8:32am
10-Q
2020 Q2
PDLI
PDL Biopharma Inc
Quarterly report
10 Aug 20
12:00am
DEFA14A
PDLI
PDL Biopharma Inc
6 Aug 20
Additional proxy soliciting materials
4:12pm
DEFA14A
PDLI
PDL Biopharma Inc
6 Aug 20
Additional proxy soliciting materials
4:10pm
8-K
PDLI
PDL Biopharma Inc
6 Aug 20
PDL BioPharma Reports 2020 Second Quarter Financial Results
4:07pm
8-K
PDLI
PDL Biopharma Inc
30 Jul 20
PDL BioPharma Enters Into Agreement for the Divestiture of the Noden Pharmaceutical Business to Stanley Capital
8:44am
8-K
PDLI
PDL Biopharma Inc
28 Jul 20
Departure of Directors or Certain Officers
4:17pm
8-K
PDLI
PDL Biopharma Inc
16 Jul 20
Results of Operations and Financial Condition
9:43pm
UPLOAD
PDLI
PDL Biopharma Inc
8 Jul 20
Letter from SEC
12:00am
DEF 14A
PDLI
PDL Biopharma Inc
Definitive proxy
7 Jul 20
1:23pm
CORRESP
PDLI
PDL Biopharma Inc
2 Jul 20
Correspondence with SEC
12:00am
UPLOAD
PDLI
PDL Biopharma Inc
2 Jul 20
Letter from SEC
12:00am
PRER14A
PDLI
PDL Biopharma Inc
Preliminary revised proxy
30 Jun 20
5:02pm
8-K
PDLI
PDL Biopharma Inc
29 Jun 20
Other Events
12:00am
CORRESP
PDLI
PDL Biopharma Inc
24 Jun 20
Correspondence with SEC
12:00am
8-K
PDLI
PDL Biopharma Inc
23 Jun 20
Other Events
4:05pm
UPLOAD
PDLI
PDL Biopharma Inc
19 Jun 20
Letter from SEC
12:00am
PRER14A
PDLI
PDL Biopharma Inc
5 Jun 20
Preliminary revised proxy
4:22pm
CORRESP
PDLI
PDL Biopharma Inc
5 Jun 20
Correspondence with SEC
12:00am